John Dingell: 40% of drugs, 80% of ingredients are from overseas, mainly China, India.
We have no monitoring system to prevent counterfeit or contaminated drugs, he writes.
Dingell: The FDA lacks the authorization to ensure these drugs meet U.S. standards.
We need to pass legislation that gives FDA proper funding and authority, he says.
